Author

Nagham Alouche

University of LausanneORCID 0000-0002-0695-5612Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Camilla JandusiD· 1 shared Daniel A. BenamraniD· 1 shared Emma DespondsiD· 1 shared Giulio Zanette· 1 shared Grégory VerdeiliD· 1 shared Hajar El AhanidiiD· 1 shared Hana ZdimerovaiD· 1 shared Hélène Maby-El HajjamiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Camilla JandusORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting CXCR4-expressing TAMs in muscle-invasive bladder cancer to enhance tumor control after immunotherapy

Emma Desponds, Hajar El Ahanidi, Nagham Alouche, Hana Zdimerova, Stéphanie Favre, Giulio Zanette, Sina Nassiri, Daniel A. Benamran, Petros K. Tsantoulis, Mohammed Attaleb, Hélène Maby-El Hajjami, Julien Dagher, Vanessa Gourhand, Karl Balabanian, Marion Espéli, , Grégory Verdeil

This study identifies CXCR4-expressing tumor-associated macrophages in bladder cancer and shows that targeting them improves immunotherapy outcomes in mice and patients.

bioRxiv · Mar 21, 2025 · PreprintImmunology